# Biocartis Group NV: Form D filing

Biocartis Group NV, a biotechnology company in Mechelen, Belgium, filed a Form D with the SEC in 2018. The latest, on October 4, 2018, reports $138,427 sold of a $138,427 offering to 1 investor.

Find out what Biocartis Group NV does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Biocartis%20Group%20NV%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Biocartis%20Group%20NV&page=%2Fdata%2Fform-d%2Fcompany%2Fbiocartis-group-nv-1754633)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Biocartis%20Group%20NV%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Biocartis%20Group%20NV&page=%2Fdata%2Fform-d%2Fcompany%2Fbiocartis-group-nv-1754633)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: GENERAAL DE WITTELAAN 11B, Mechelen, Belgium, 2800
- Phone: (321) 563-2600
- Industry: Biotechnology
- Entity type: Other (A public company with limited liability, incorporated under the laws of Belgium.)
- Incorporated in: Belgium
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 504
- SEC identifier (CIK): 1754633

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 4, 2018 | New notice | $138,427 | $138,427 | $0 | 1 | Sep 10, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1754633/000175463318000001/0001754633-18-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Herman Verrelst | Executive Officer |  |

[Every Form D from the week of Oct 1, 2018](https://specstream.ai/data/form-d/week/2018-10-01) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Biocartis Group NV reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).